{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T03:56:23Z","timestamp":1794974183060,"version":"4.9.1"},"reference-count":159,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T00:00:00Z","timestamp":1748476800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T00:00:00Z","timestamp":1748476800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Italian Ministry of Health","doi-asserted-by":"crossref","award":["RC278859"],"award-info":[{"award-number":["RC278859"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003196","name":"Italian Ministry of Health","doi-asserted-by":"crossref","award":["RF-2021-12374301"],"award-info":[{"award-number":["RF-2021-12374301"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100015822","name":"Fondazione Roma","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100015822","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Fondo Ordinario Enti funds in the framework of a collaboration agreement between the Italian National Research Council and EBRI","award":["FOE D.M865\/2019"],"award-info":[{"award-number":["FOE D.M865\/2019"]}]},{"name":"Fondo Ordinario Enti funds in the framework of a collaboration agreement between the Italian National Research Council and EBRI","award":["FOE D.M865\/2019"],"award-info":[{"award-number":["FOE D.M865\/2019"]}]},{"name":"Alzheimer's Association Research Grant","award":["Proposal ID: 971925"],"award-info":[{"award-number":["Proposal ID: 971925"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"DOI":"10.1186\/s40478-025-02022-y","type":"journal-article","created":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T12:14:13Z","timestamp":1748520853000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Acute targeting of N-terminal tau protein has long-lasting beneficial effects in Tg2576 APP\/A\u03b2 mouse model by reducing cognitive impairment, cerebral A\u03b2-amyloidosis, synaptic remodeling and microgliosis later in life"],"prefix":"10.1186","volume":"13","author":[{"given":"Valentina","family":"Latina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margherita","family":"De Introna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Malerba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Florio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bijorn Omar","family":"Balzamino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Di Natale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele Francesco Maria","family":"Sciacca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Pappalardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Micera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annabella","family":"Pignataro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Calissano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2080-2951","authenticated-orcid":false,"given":"Giuseppina","family":"Amadoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,29]]},"reference":[{"issue":"12","key":"2022_CR1","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.4103\/1673-5374.313043","volume":"16","author":"G Amadoro","year":"2021","unstructured":"Amadoro G, Latina V, Calissano P (2021) A long story for a short peptide: therapeutic efficacy of a cleavage-specific tau antibody. Neural Regen Res 16(12):2417\u20132419. https:\/\/doi.org\/10.4103\/1673-5374.313043","journal-title":"Neural Regen Res"},{"issue":"1","key":"2022_CR2","doi-asserted-by":"publisher","first-page":"039","DOI":"10.1093\/braincomms\/fcaa039","volume":"2","author":"V Corsetti","year":"2020","unstructured":"Corsetti V, Borreca A, Latina V, Giacovazzo G, Pignataro A, Krashia P, Natale F, Cocco S, Rinaudo M, Malerba F, Florio R, Ciarapica R, Coccurello R, D\u2019Amelio M, Ammassari-Teule M, Grassi C, Calissano P, Amadoro G (2020) Passive immunotherapy for N-truncated tau ameliorates the cognitive deficits in two mouse Alzheimer\u2019s disease models. Brain Commun 2(1):039. https:\/\/doi.org\/10.1093\/braincomms\/fcaa039","journal-title":"Brain Commun"},{"issue":"22","key":"2022_CR3","doi-asserted-by":"publisher","first-page":"4757","DOI":"10.1016\/j.cell.2023.09.023","volume":"186","author":"AL Boxer","year":"2023","unstructured":"Boxer AL, Sperling R (2023) Accelerating Alzheimer\u2019s therapeutic development: the past and future of clinical trials. Cell 186(22):4757\u20134772. https:\/\/doi.org\/10.1016\/j.cell.2023.09.023","journal-title":"Cell"},{"issue":"8","key":"2022_CR4","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s40263-024-01103-1","volume":"38","author":"JL Cummings","year":"2024","unstructured":"Cummings JL, Osse AML, Kinney JW, Cammann D, Chen J (2024) Alzheimer\u2019s disease: combination therapies and clinical trials for combination therapy development. CNS Drugs 38(8):613\u2013624. https:\/\/doi.org\/10.1007\/s40263-024-01103-1","journal-title":"CNS Drugs"},{"issue":"10284","key":"2022_CR5","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","volume":"397","author":"P Scheltens","year":"2021","unstructured":"Scheltens P, De Strooper B, Kivipelto M, Holstege H, Ch\u00e9telat G, Teunissen CE, Cummings J, van der Flier WM (2021) Alzheimer\u2019s disease. Lancet 397(10284):1577\u20131590. https:\/\/doi.org\/10.1016\/S0140-6736(20)32205-4","journal-title":"Lancet"},{"issue":"1","key":"2022_CR6","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13024-019-0333-5","volume":"14","author":"MA DeTure","year":"2019","unstructured":"DeTure MA, Dickson DW (2019) The neuropathological diagnosis of Alzheimer\u2019s disease. Mol Neurodegener 14(1):32. https:\/\/doi.org\/10.1186\/s13024-019-0333-5","journal-title":"Mol Neurodegener"},{"issue":"2","key":"2022_CR7","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/nrn2967","volume":"12","author":"LM Ittner","year":"2011","unstructured":"Ittner LM, G\u00f6tz J (2011) Amyloid-\u03b2 and tau\u2013a toxic pas de deux in Alzheimer\u2019s disease. Nat Rev Neurosci 12(2):65\u201372. https:\/\/doi.org\/10.1038\/nrn2967","journal-title":"Nat Rev Neurosci"},{"issue":"2","key":"2022_CR8","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s00401-014-1371-2","volume":"129","author":"RM Nisbet","year":"2015","unstructured":"Nisbet RM, Polanco JC, Ittner LM, G\u00f6tz J (2015) Tau aggregation and its interplay with amyloid-beta. Acta Neuropathol 129(2):207\u2013220. https:\/\/doi.org\/10.1007\/s00401-014-1371-2","journal-title":"Acta Neuropathol"},{"issue":"47","key":"2022_CR9","doi-asserted-by":"publisher","first-page":"20057","DOI":"10.1073\/pnas.0905529106","volume":"106","author":"V Rhein","year":"2009","unstructured":"Rhein V, Song X, Wiesner A, Ittner LM, Baysang G, Meier F, Ozmen L, Bluethmann H, Dr\u00f6se S, Brandt U, Savaskan E, Czech C, G\u00f6tz J, Eckert A (2009) Amyloid-beta and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer\u2019s disease mice. Proc Natl Acad Sci U S A 106(47):20057\u201320062. https:\/\/doi.org\/10.1073\/pnas.0905529106","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"2022_CR10","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/mp.2016.37","volume":"22","author":"TA Pascoal","year":"2017","unstructured":"Pascoal TA, Mathotaarachchi S, Mohades S, Benedet AL, Chung C-O, Shin M, Wang S, Beaudry T, Kang MS, Soucy J-P, Labbe A, Gauthier S, Rosa-Neto P (2017) Amyloid-\u03b2 and hyperphosphorylated tau synergy drives metabolic decline in preclinical Alzheimer\u2019s disease. Mol Psychiatry 22(2):306\u2013311. https:\/\/doi.org\/10.1038\/mp.2016.37","journal-title":"Mol Psychiatry"},{"issue":"4","key":"2022_CR11","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1002\/ana.22509","volume":"70","author":"RS Desikan","year":"2011","unstructured":"Desikan RS, McEvoy LK, Thompson WK, Holland D, Roddey JC, Blennow K, Aisen PS, Brewer JB, Hyman BT, Dale AM, Alzheimer\u2019s Disease Neuroimaging Initiative (2011) Amyloid-\u03b2 associated volume loss occurs only in the presence of phospho-tau. Ann Neurol 70(4):657\u2013661. https:\/\/doi.org\/10.1002\/ana.22509","journal-title":"Ann Neurol"},{"issue":"2","key":"2022_CR12","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1002\/ana.24186","volume":"76","author":"J Fortea","year":"2014","unstructured":"Fortea J, Vilaplana E, Alcolea D, Carmona-Iragui M, S\u00e1nchez-Saudinos MB, Sala I, Ant\u00f3n-Aguirre S, Gonz\u00e1lez S, Medrano S, Pegueroles J, Morenas E, Clarim\u00f3n J, Blesa R, Lle\u00f3 A, Initiative ADN (2014) Cerebrospinal fluid \u03b2-amyloid and phospho-tau biomarker interactions affecting brain structure in preclinical Alzheimer disease. Ann Neurol 76(2):223\u2013230. https:\/\/doi.org\/10.1002\/ana.24186","journal-title":"Ann Neurol"},{"key":"2022_CR13","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.neurobiolaging.2019.03.016","volume":"79","author":"M Timmers","year":"2019","unstructured":"Timmers M, Tesseur I, Bogert J, Zetterberg H, Blennow K, B\u00f6rjesson-Hanson A, Baquero M, Boada M, Randolph C, Tritsmans L, Nueten LV, Engelborghs S, Streffer JR (2019) Relevance of the interplay between amyloid and tau for cognitive impairment in early Alzheimer\u2019s disease. Neurobiol Aging 79:131\u2013141","journal-title":"Neurobiol Aging"},{"issue":"8","key":"2022_CR14","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.4103\/1673-5374.332127","volume":"17","author":"AR Roda","year":"2022","unstructured":"Roda AR, Serra-Mir G, Montoliu-Gaya L, Tiessler L, Villegas S (2022) Amyloid-beta peptide and tau protein crosstalk in Alzheimer\u2019s disease. Neural Regen Res 17(8):1666\u20131674. https:\/\/doi.org\/10.4103\/1673-5374.332127","journal-title":"Neural Regen Res"},{"issue":"1","key":"2022_CR15","doi-asserted-by":"publisher","first-page":"e12073","DOI":"10.10002\/trc2.12073","volume":"6","author":"SP Salloway","year":"2020","unstructured":"Salloway SP, Sevingy J, Budur K, Torleif Pederson J, DeMattos RB, Von Rosenstiel P, Paez A, Evans R, Weber CJ, Hendrix JA, Worley S, Bain LJ, Carrillo MC (2020) Advancing combination therapy for Alzheimer\u2019s disease. Alzheimer\u2019s Dementia Transl Res Clin Interv 6(1):e12073. https:\/\/doi.org\/10.10002\/trc2.12073","journal-title":"Alzheimer's Dementia Transl Res Clin Interv"},{"issue":"10","key":"2022_CR16","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1038\/s41593-020-0687-6","volume":"23","author":"MA Busche","year":"2020","unstructured":"Busche MA, Hyman BT (2020) Synergy between amyloid-\u03b2 and tau in Alzheimer\u2019s disease. Nat Neurosci 23(10):1183\u20131193. https:\/\/doi.org\/10.1038\/s41593-020-0687-6","journal-title":"Nat Neurosci"},{"issue":"7","key":"2022_CR17","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1038\/s41374-019-0231-z","volume":"99","author":"RJ Castellani","year":"2019","unstructured":"Castellani RJ, Plascencia-Villa G, Perry G (2019) The amyloid cascade and Alzheimer\u2019s disease therapeutics: theory versus observation. Lab Invest 99(7):958\u2013970. https:\/\/doi.org\/10.1038\/s41374-019-0231-z","journal-title":"Lab Invest"},{"issue":"2","key":"2022_CR18","doi-asserted-by":"publisher","first-page":"e12779","DOI":"10.1111\/nan.12779","volume":"48","author":"EJ Koller","year":"2022","unstructured":"Koller EJ, Ibanez KR, Vo Q, McFarland KN, De La Cruz EG, Zobel L, Williams T, Xu G, Ryu D, Patel P, Giasson BI, Prokop S, Chakrabarty P (2022) Combinatorial model of amyloid \u03b2 and tau reveals synergy between amyloid deposits and tangle formation. Neuropathol Appl Neurobiol 48(2):e12779. https:\/\/doi.org\/10.1111\/nan.12779","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2022_CR19","doi-asserted-by":"publisher","first-page":"165584","DOI":"10.1016\/j.bbadis.2019.165584","volume":"3","author":"G Amadoro","year":"1866","unstructured":"Amadoro G, Latina V, Corsetti V (1866) Calissano P (2020) N-terminal tau truncation in the pathogenesis of Alzheimer\u2019s disease (AD): developing a novel diagnostic and therapeutic approach. Biochim Biophys Acta Mol Basis Dis 3:165584. https:\/\/doi.org\/10.1016\/j.bbadis.2019.165584","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"22","key":"2022_CR20","doi-asserted-by":"publisher","first-page":"12158","DOI":"10.3390\/ijms222212158","volume":"22","author":"V Latina","year":"2021","unstructured":"Latina V, Giacovazzo G, Calissano P, Atlante A, La Regina F, Malerba F, Dell\u2019Aquila M, Stigliano E, Balzamino BO, Micera A, Coccurello R, Amadoro G (2021) Tau cleavage contributes to cognitive dysfunction in strepto-zotocin-induced sporadic Alzheimer\u2019s disease (sAD) mouse model. Int J Mol Sci 22(22):12158. https:\/\/doi.org\/10.3390\/ijms222212158","journal-title":"Int J Mol Sci"},{"issue":"2","key":"2022_CR21","doi-asserted-by":"publisher","first-page":"509","DOI":"10.3390\/pharmaceutics15020509","volume":"15","author":"V Latina","year":"2023","unstructured":"Latina V, De Introna M, Caligiuri C, Loviglio A, Florio R, La Regina F, Pignataro A, Ammassari-Teule M, Calissano P, Amadoro G (2023) Immunotherapy with cleavage-specific 12A12mAb reduces the tau cleavage in visual cortex and improves visuo-spatial recognition memory in Tg2576 AD mouse model. Pharmaceutics 15(2):509. https:\/\/doi.org\/10.3390\/pharmaceutics15020509","journal-title":"Pharmaceutics"},{"issue":"11","key":"2022_CR22","doi-asserted-by":"publisher","first-page":"9683","DOI":"10.3390\/ijms24119683","volume":"24","author":"V Latina","year":"2023","unstructured":"Latina V, Atlante A, Malerba F, La Regina F, Balzamino BO, Micera A, Pignataro A, Stigliano E, Cavallaro S, Calissano P, Amadoro G (2023) The cleavage-specific Tau 12A12mAb exerts an anti-amyloidogenic action by modulating the endocytic and bioenergetic pathways in Alzheimer\u2019s disease mouse model. Int J Mol Sci 24(11):9683. https:\/\/doi.org\/10.3390\/ijms24119683","journal-title":"Int J Mol Sci"},{"issue":"18","key":"2022_CR23","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.3390\/cells12182254","volume":"12","author":"G Morello","year":"2023","unstructured":"Morello G, Guarnaccia M, La Cognata V, Latina V, Calissano P, Amadoro G, Cavallaro, S (2023) Transcriptomic analysis in the hippocampus and retina of Tg2576 AD mice reveals defective mitochondrial oxidative phosphorylation and recovery by Tau 12A12mAb treatment. Cells 12(18):2254. https:\/\/doi.org\/10.3390\/cells12182254","journal-title":"Cells"},{"issue":"5284","key":"2022_CR24","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1126\/science.274.5284.99","volume":"274","author":"K Hsiao","year":"1996","unstructured":"Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S, Yang F, Cole G (1996) Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 274(5284):99\u2013102. https:\/\/doi.org\/10.1126\/science.274.5284.99","journal-title":"Science"},{"issue":"9","key":"2022_CR25","doi-asserted-by":"publisher","first-page":"e7134","DOI":"10.1371\/journal.pone.0007134","volume":"4","author":"J Morales-Corraliza","year":"2009","unstructured":"Morales-Corraliza J, Mazzella MJ, Berger JD, Diaz NS, Choi JHK, Levy E, Matsuoka Y, Planel E, Mathews PM (2009) In vivo turnover of Tau and APP metabolites in the brains of wild-type and Tg2576 mice: greater stability of sAPP in the \u03b2-amyloid depositing mice. PLoS ONE 4(9):e7134. https:\/\/doi.org\/10.1371\/journal.pone.0007134","journal-title":"PLoS ONE"},{"issue":"2","key":"2022_CR26","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1523\/JNEUROSCI.21-02-00372.2001","volume":"21","author":"T Kawarabayashi","year":"2001","unstructured":"Kawarabayashi T, Younkin LH, Saido TC, Shoji M, Ashe KH, Younkin SG (2001) Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer\u2019s disease. J Neurosci 21(2):372\u2013381. https:\/\/doi.org\/10.1523\/JNEUROSCI.21-02-00372.2001","journal-title":"J Neurosci"},{"issue":"9","key":"2022_CR27","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1097\/00005072-199709000-00002","volume":"56","author":"MC Irizarry","year":"1997","unstructured":"Irizarry MC, McNamara M, Fedorchak K, Hsiao K, Hyman BT (1997) APPSw transgenic mice develop age-related A beta deposits and neuropil abnormalities, but no neuronal loss in CA1. J Neuropathol Exp Neurol 56(9):965\u2013973. https:\/\/doi.org\/10.1097\/00005072-199709000-00002","journal-title":"J Neuropathol Exp Neurol"},{"issue":"5","key":"2022_CR28","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s00401-004-0907-2","volume":"108","author":"K Noda-Saita","year":"2004","unstructured":"Noda-Saita K, Terai K, Iwai A, Tsukamoto M, Shitaka Y, Y, Kawabata S, Okada M, Yamaguchi T, (2004) Exclusive association and simultaneous appearance of congophilic plaques and AT8-positive dystrophic neurites in Tg2576 mice suggest a mechanism of senile plaque formation and progression of neuritic dystrophy in Alzheimer\u2019s disease. Acta Neuropathol 108(5):435\u2013442. https:\/\/doi.org\/10.1007\/s00401-004-0907-2","journal-title":"Acta Neuropathol"},{"key":"2022_CR29","doi-asserted-by":"publisher","first-page":"702788","DOI":"10.3389\/fnins.2021.702788","volume":"15","author":"B Boyarko","year":"2021","unstructured":"Boyarko B, Hook V (2021) Human tau isoforms and proteolysis for production of toxic tau fragments in neurodegeneration. Front Neurosci 15:702788. https:\/\/doi.org\/10.3389\/fnins.2021.702788","journal-title":"Front Neurosci"},{"issue":"1","key":"2022_CR30","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3233\/JAD-170959","volume":"63","author":"JP Quinn","year":"2018","unstructured":"Quinn JP, Corbett NJ, Kellett KAB, Hooper NM (2018) Tau proteolysis in the pathogenesis of tauopathies: neurotoxic fragments and novel biomarkers. J Alzheimers Dis 63(1):13\u201333. https:\/\/doi.org\/10.3233\/JAD-170959","journal-title":"J Alzheimers Dis"},{"issue":"6","key":"2022_CR31","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.4103\/1673-5374.385853","volume":"19","author":"D Chu","year":"2024","unstructured":"Chu D, Yang X, Wang J, Zhou Y, Gu JH, Miao J, Wu F, Liu F (2024) Tau truncation in the pathogenesis of Alzheimer\u2019s disease: a narrative review. Neural Regen Res. 19(6):1221\u201332","journal-title":"Neural Regen Res."},{"issue":"17","key":"2022_CR32","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.15252\/embj.201797397","volume":"36","author":"H Sasaguri","year":"2017","unstructured":"Sasaguri H, Nilsson P, Hashimoto S, Nagata K, Saito T, De Strooper B, Hardy J, Vassar R, Winblad B, Saido TC (2017) APP mouse models for Alzheimer\u2019s disease preclinical studies. EMBO J 36(17):2473\u20132487. https:\/\/doi.org\/10.15252\/embj.201797397","journal-title":"EMBO J"},{"issue":"4","key":"2022_CR33","doi-asserted-by":"publisher","first-page":"833.e1","DOI":"10.1016\/j.neurobiolaging.2011.08.001","volume":"33","author":"G Amadoro","year":"2012","unstructured":"Amadoro G, Corsetti V, Atlante A, Florenzano F, Capsoni S, Bussani R, Mercanti D, Calissano P (2012) Interaction between NH(2)-tau fragment and A\u03b2 in Alzheimer\u2019s disease mitochondria contributes to the synaptic deterioration. Neurobiol Aging 33(4):833.e1\u201325. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2011.08.001","journal-title":"Neurobiol Aging"},{"issue":"39","key":"2022_CR34","doi-asserted-by":"publisher","first-page":"64745","DOI":"10.18632\/oncotarget.17371","volume":"8","author":"F Florenzano","year":"2017","unstructured":"Florenzano F, Corsetti V, Ciasca G, Ciotti MT, Pittaluga A, Olivero G, Feligioni M, Iannuzzi F, Latina V, Sciacca MFM, Sinopoli A, Milardi D, Pappalardo G, De Spirito M, Papi M, Atlante A, Bobba A, Borreca A, Calissano P, Amadoro G (2017) Extracellular truncated tau causes early presynaptic dysfunction associated with Alzheimer\u2019s disease and other tauopathies. Oncotarget 8(39):64745\u201364778. https:\/\/doi.org\/10.18632\/oncotarget.17371","journal-title":"Oncotarget"},{"issue":"1","key":"2022_CR35","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1136\/mp.52.1.11","volume":"52","author":"S Mort","year":"1999","unstructured":"Mort S, Buttle DJ (1999) The use of cleavage site specific antibodies to delineate protein processing and breakdown pathways. Mol Pathol 52(1):11\u201318. https:\/\/doi.org\/10.1136\/mp.52.1.11","journal-title":"Mol Pathol"},{"issue":"2","key":"2022_CR36","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1006\/nbdi.2002.0549","volume":"11","author":"TT Rohn","year":"2002","unstructured":"Rohn TT, Rissman RA, Davis MC, Kim YE, Cotman CW, Head E (2002) Caspase-9 activation and caspase cleavage of tau in the Alzheimer\u2019s disease brain. Neurobiol Dis 11(2):341\u2013354. https:\/\/doi.org\/10.1006\/nbdi.2002.0549","journal-title":"Neurobiol Dis"},{"issue":"3","key":"2022_CR37","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.mcn.2008.03.011","volume":"38","author":"V Corsetti","year":"2008","unstructured":"Corsetti V, Amadoro G, Gentile A, Capsoni S, Ciotti MT, Cencioni MT, Atlante A, Canu N, Rohn TT, Cattaneo A, Calissano P (2008) Identification of a caspase-derived N-terminal tau fragment in cellular and animal Alzheimer\u2019s disease models. Mol Cell Neurosci 38(3):381\u2013392. https:\/\/doi.org\/10.1016\/j.mcn.2008.03.011","journal-title":"Mol Cell Neurosci"},{"issue":"10","key":"2022_CR38","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1016\/j.neuron.2024.02.017","volume":"112","author":"D Zhang","year":"2024","unstructured":"Zhang D, Zhang W, Ming C, Gao X, Yuan H, Lin X, Mao X, Wang C, Guo X, Du Y, Shao L, Yang R, Lin Z, Wu X, Huang TY, Wang Z, Zhang YW, Xu H, Zhao Y (2024) P-tau217 correlates with neurodegeneration in Alzheimer\u2019s disease, and targeting p-tau217 with immunotherapy ameliorates murine tauopathy. Neuron 112(10):1676-1693.e12. https:\/\/doi.org\/10.1016\/j.neuron.2024.02.017","journal-title":"Neuron"},{"key":"2022_CR39","doi-asserted-by":"publisher","DOI":"10.1101\/2024.05.21.595198","author":"A Mart\u00edn-\u00c1vila","year":"2024","unstructured":"Mart\u00edn-\u00c1vila A, Modak SR, Rajamohamedsait HB, Dodge A, Shamir DB, Krishnaswamy S, Sandusky-Beltran LA, Walker M, Lin J, Congdon EE, Sigurdsson EM (2024) Clearing truncated tau protein restores neuronal function and prevents microglia activation in tauopathy mice. Biorxiv. https:\/\/doi.org\/10.1101\/2024.05.21.595198","journal-title":"Biorxiv"},{"issue":"3","key":"2022_CR40","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1016\/j.neurobiolaging.2014.11.022","volume":"36","author":"AJ Mably","year":"2015","unstructured":"Mably AJ, Kanmert D, Mc Donald JM, Liu W, Caldarone BJ, Lemere CA, O\u2019Nuallain B, Kosik KS, Walsh DM (2015) Tau immunization: a cautionary tale? Neurobiol Aging 36(3):1316\u20131332. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2014.11.022","journal-title":"Neurobiol Aging"},{"issue":"10","key":"2022_CR41","doi-asserted-by":"publisher","first-page":"8124","DOI":"10.1007\/s12035-018-0974-3","volume":"55","author":"A Borreca","year":"2018","unstructured":"Borreca A, Latina V, Corsetti V, Middei S, Piccinin S, Della Valle F, Bussani R, Ammassari-Teule M, Nistic\u00f2 R, Calissano P, Amadoro G (2018) AD-related N-terminal truncated tau is sufficient to recapitulate in vivo the early perturbations of human neuropathology: implications for immunotherapy. Mol Neurobiol 55(10):8124\u20138153. https:\/\/doi.org\/10.1007\/s12035-018-0974-3","journal-title":"Mol Neurobiol"},{"issue":"2","key":"2022_CR42","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/sj.cdd.4401314","volume":"11","author":"G Amadoro","year":"2004","unstructured":"Amadoro G, Serafino AL, Barbato C, Ciotti MT, Sacco A, Calissano P, Canu N (2004) Role of N-terminal tau domain integrity on the survival of cerebellar granule neurons. Cell Death Differ 11(2):217\u2013230. https:\/\/doi.org\/10.1038\/sj.cdd.4401314","journal-title":"Cell Death Differ"},{"issue":"8","key":"2022_CR43","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.1073\/pnas.0511065103","volume":"103","author":"G Amadoro","year":"2006","unstructured":"Amadoro G, Ciotti MT, Costanzi M, Cestari V, Calissano P, Canu N (2006) NMDA receptor mediates tau-induced neurotoxicity by calpain and ERK\/MAPK activation. Proc Natl Acad Sci U S A 103(8):2892\u20132897. https:\/\/doi.org\/10.1073\/pnas.0511065103","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"2022_CR44","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s10339-011-0430-z","volume":"13","author":"M Antunes","year":"2012","unstructured":"Antunes M, Biala G (2012) The novel object recognition memory: neurobiology, test procedure, and its modifications. Cogn Process 13(2):93\u2013110. https:\/\/doi.org\/10.1007\/s10339-011-0430-z","journal-title":"Cogn Process"},{"issue":"1","key":"2022_CR45","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1101\/lm.1121309","volume":"16","author":"GR Barker","year":"2008","unstructured":"Barker GR, Warburton EC (2008) Critical role of the cholinergic system for object-in-place associative recognition memory. Learn Mem 16(1):8\u201311. https:\/\/doi.org\/10.1101\/lm.1121309","journal-title":"Learn Mem"},{"issue":"2","key":"2022_CR46","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.bbr.2009.12.036","volume":"215","author":"A Ennaceur","year":"2010","unstructured":"Ennaceur A (2010) One-trial object recognition in rats and mice: methodological and theoretical issues. Behav Brain Res 215(2):244\u2013254. https:\/\/doi.org\/10.1016\/j.bbr.2009.12.036","journal-title":"Behav Brain Res"},{"issue":"2","key":"2022_CR47","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/0003-2697(87)90587-2","volume":"166","author":"H Sch\u00e4gger","year":"1987","unstructured":"Sch\u00e4gger H, von Jagow G (1987) Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal Biochem 166(2):368\u2013379. https:\/\/doi.org\/10.1016\/0003-2697(87)90587-2","journal-title":"Anal Biochem"},{"issue":"5618","key":"2022_CR48","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1126\/science.1079469","volume":"300","author":"R Kayed","year":"2003","unstructured":"Kayed R, Head E, Thompson JL, McIntire TM, Milton SC, Cotman CW, Glabe CG (2003) Common structure of soluble amyloid oligomers implies commonmechanism of pathogenesis. Science 300(5618):486\u2013489. https:\/\/doi.org\/10.1126\/science.1079469","journal-title":"Science"},{"key":"2022_CR49","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1750-1326-2-18","volume":"2","author":"R Kayed","year":"2007","unstructured":"Kayed R, Head E, Sarsoza F, Saing T, Cotman CW, Necula M, Margol L, Wu J, Breydo L, Thompson JL, Rasool S, Gurlo T, Butler P, Glabe CG (2007) Fibrilspecific, conformation dependent antibodies recognize a generic epitopecommon to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers. Mol Neurodegener 2:18. https:\/\/doi.org\/10.1186\/1750-1326-2-18","journal-title":"Mol Neurodegener"},{"issue":"2","key":"2022_CR50","doi-asserted-by":"publisher","first-page":"e00006","DOI":"10.1042\/AN20090015","volume":"1","author":"I Lefterov","year":"2009","unstructured":"Lefterov I, Fitz NF, Cronican A, Lefterov P, Staufenbiel M, Koldamova R (2009) Memory deficits in APP23\/Abca1+\/- mice correlate with the level of A\u03b2 oligomers. ASN Neuro 1(2):e00006. https:\/\/doi.org\/10.1042\/AN20090015","journal-title":"ASN Neuro"},{"issue":"5","key":"2022_CR51","doi-asserted-by":"publisher","first-page":"e0126317","DOI":"10.1371\/journal.pone.0126317","volume":"10","author":"P Liu","year":"2015","unstructured":"Liu P, Paulson JB, Forster CL, Shapiro SL, Ashe KH, Zahs KR (2015) Characterization of a novel mouse model of Alzheimer\u2019s disease-amyloid pathology and unique \u03b2-amyloid oligomer profile. PLoS ONE 10(5):e0126317. https:\/\/doi.org\/10.1371\/journal.pone.0126317","journal-title":"PLoS ONE"},{"issue":"11","key":"2022_CR52","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1016\/j.celrep.2015.05.021","volume":"11","author":"P Liu","year":"2015","unstructured":"Liu P, Reed MN, Kotilinek LA, Grant MKO, Forster CL, Qiang W, Shapiro SL, Reichl JH, Chiang ACA, Jankowsky JL, Wilmot CM, Cleary JP, Zahs KR, Ashe KH (2015) Quaternary structure defines a large class of amyloid-\u03b2 oligomers neutralized by sequestration. Cell Rep 11(11):1760\u20131771. https:\/\/doi.org\/10.1016\/j.celrep.2015.05.021","journal-title":"Cell Rep"},{"key":"2022_CR53","volume-title":"The mouse brain in stereotaxic coordinates","author":"G Paxinos","year":"2001","unstructured":"Paxinos G, Franklin KBJ (2001) The mouse brain in stereotaxic coordinates, 2nd edn. Academic Press, New York, NY, USA","edition":"2"},{"issue":"3","key":"2022_CR54","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1038\/nprot.2006.205","volume":"1","author":"RA Bevins","year":"2006","unstructured":"Bevins RA, Besheer J (2006) Object recognition in rats and mice: a onetrial non-matching-to-sample learning task to study \u201crecognition memory.\u201d Nat Protoc 1(3):1306\u20131311. https:\/\/doi.org\/10.1038\/nprot.2006.205","journal-title":"Nat Protoc"},{"issue":"23","key":"2022_CR55","doi-asserted-by":"publisher","first-page":"8853","DOI":"10.1523\/JNEUROSCI.20-23-08853.2000","volume":"20","author":"RE Clark","year":"2000","unstructured":"Clark RE, Zola SM, Squire LR (2000) Impaired recognition memory in rats after damage to the hippocampus. J Neurosci 20(23):8853\u20138860. https:\/\/doi.org\/10.1523\/JNEUROSCI.20-23-08853.2000","journal-title":"J Neurosci"},{"issue":"1","key":"2022_CR56","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3233\/JAD-2011-101827","volume":"26","author":"S Stewart","year":"2011","unstructured":"Stewart S, Cacucci F, Lever C (2011) Which memory task for my mouse? A systematic review of spatial memory performance in the Tg2576 Alzheimer\u2019s mouse model. J Alzheimers Dis 26(1):105\u2013126. https:\/\/doi.org\/10.3233\/JAD-2011-101827","journal-title":"J Alzheimers Dis"},{"key":"2022_CR57","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.bbr.2014.10.025","volume":"285","author":"B Grayson","year":"2015","unstructured":"Grayson B, Leger M, Piercy C, Adamson L, Harte M, Neill JC (2015) Assessment of disease-related cognitive impairments using the novel object recognition (NOR) task in rodents. Behav Brain Res 285:176\u2013193. https:\/\/doi.org\/10.1016\/j.bbr.2014.10.025","journal-title":"Behav Brain Res"},{"issue":"Pt 12","key":"2022_CR58","doi-asserted-by":"publisher","first-page":"3319","DOI":"10.1093\/brain\/awu280","volume":"137","author":"MM Dorostkar","year":"2014","unstructured":"Dorostkar MM, Burgold S, Filser S, Barghorn S, Schmidt B, Anumala UR, Hillen H, Klein C, Herms J (2014) Immunotherapy alleviates amyloid-associated synaptic pathology in an Alzheimer\u2019s disease mouse model. Brain 137(Pt 12):3319\u20133326. https:\/\/doi.org\/10.1093\/brain\/awu280","journal-title":"Brain"},{"issue":"1","key":"2022_CR59","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.neurobiolaging.2012.04.007","volume":"34","author":"J Morales-Corraliza","year":"2013","unstructured":"Morales-Corraliza J, Schmidt SD, Mazzella MJ, Berger JD, Wilson DA, Wesson DW, Jucker M, Levy E, Nixon RA, Mathews PM (2013) Immunization targeting a minor plaque constituent clears \u03b2-amyloid and rescues behavioral deficits in an Alzheimer\u2019s disease mouse model. Neurobiol Aging 34(1):137\u2013145. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2012.04.007","journal-title":"Neurobiol Aging"},{"issue":"12","key":"2022_CR60","doi-asserted-by":"publisher","first-page":"4857","DOI":"10.1523\/JNEUROSCI.4989-14.2015","volume":"35","author":"DL Castillo-Carranza","year":"2015","unstructured":"Castillo-Carranza DL, Guerrero-Mu\u00f1oz MJ, Sengupta U, Hernandez C, Barrett ADT, Dineley K, Kayed R (2015) Tau immunotherapy modulates both pathological tau and upstream amyloid pathology in an Alzheimer\u2019s disease mouse model. J Neurosci 35(12):4857\u20134868. https:\/\/doi.org\/10.1523\/JNEUROSCI.4989-14.2015","journal-title":"J Neurosci"},{"issue":"5 Pt 2","key":"2022_CR61","doi-asserted-by":"publisher","first-page":"3796","DOI":"10.1523\/JNEUROSCI.15-05-03796.1995","volume":"15","author":"P Alvarez","year":"1995","unstructured":"Alvarez P, Zola-Morgan S, Squire LR (1995) Damage limited to the hippocampal region produces long-lasting memory impairment in monkeys. J Neurosci 15(5 Pt 2):3796\u20133807. https:\/\/doi.org\/10.1523\/JNEUROSCI.15-05-03796.1995","journal-title":"J Neurosci"},{"key":"2022_CR62","doi-asserted-by":"publisher","first-page":"108777","DOI":"10.1016\/j.neuropsychologia.2023.108777","volume":"193","author":"A Yonelinas","year":"2024","unstructured":"Yonelinas A, Hawkins C, Abovian A, Aly M (2024) The role of recollection, familiarity, and the hippocampus in episodic and working memory. Neuropsychologia 193:108777. https:\/\/doi.org\/10.1016\/j.neuropsychologia.2023.108777","journal-title":"Neuropsychologia"},{"issue":"4","key":"2022_CR63","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82(4):239\u2013259. https:\/\/doi.org\/10.1007\/BF00308809","journal-title":"Acta Neuropathol"},{"issue":"1","key":"2022_CR64","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00401-015-1516-y","volume":"131","author":"YS Eisele","year":"2016","unstructured":"Eisele YS, Duyckaerts C (2016) Propagation of A\u00df pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies. Acta Neuropathol 131(1):5\u201325. https:\/\/doi.org\/10.1007\/s00401-015-1516-y","journal-title":"Acta Neuropathol"},{"issue":"12","key":"2022_CR65","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1016\/j.neuron.2022.03.034","volume":"110","author":"WJ Lee","year":"2022","unstructured":"Lee WJ, Brown JA, Kim HR, La Joie R, Cho H, Lyoo CH, Rabinovici GD, Seong JK, Seeley WW (2022) Alzheimer\u2019s disease neuroimaging initiative regional A\u03b2-tau interactions promote onset and acceleration of Alzheimer\u2019s disease tau spreading. Neuron 110(12):1932-1943.e5. https:\/\/doi.org\/10.1016\/j.neuron.2022.03.034","journal-title":"Neuron"},{"key":"2022_CR66","doi-asserted-by":"publisher","first-page":"101114","DOI":"10.1016\/j.arr.2020.101114","volume":"62","author":"ZT Wang","year":"2020","unstructured":"Wang ZT, Zhang C, Wang YJ, Dong Q, Tan L, Yu JT (2020) Selective neuronal vulnerability in Alzheimer\u2019s disease. Ageing Res Rev 62:101114. https:\/\/doi.org\/10.1016\/j.arr.2020.101114","journal-title":"Ageing Res Rev"},{"issue":"2\u20133","key":"2022_CR67","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.ijdevneu.2005.11.011","volume":"24","author":"E Kouznetsova","year":"2006","unstructured":"Kouznetsova E, Klingner M, Sorger D, Sabri O, Grossmann U, Steinbach J, Scheunemann M, Schliebs R (2006) Developmental and amyloid plaque-related changes in cerebral cortical capillaries in transgenic Tg2576 Alzheimer mice. Int J Dev Neurosci 24(2\u20133):187\u2013193. https:\/\/doi.org\/10.1016\/j.ijdevneu.2005.11.011","journal-title":"Int J Dev Neurosci"},{"key":"2022_CR68","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1196\/annals.1379.004","volume":"1097","author":"T Takano","year":"2007","unstructured":"Takano T, Han X, Deane R, Zlokovic B, Nedergaard M (2007) Two-photon imaging of astrocytic Ca2+ signaling and the microvasculature in experimental mice models of Alzheimer\u2019s disease. Ann N Y Acad Sci 1097:40\u201350. https:\/\/doi.org\/10.1196\/annals.1379.004","journal-title":"Ann N Y Acad Sci"},{"key":"2022_CR69","doi-asserted-by":"publisher","first-page":"1334360","DOI":"10.3389\/fneur.2023.1334360","volume":"14","author":"K Wang","year":"2024","unstructured":"Wang K, Zhang B, Du H, Duan H, Jiang Z, Fang S (2024) Research landscape and trends of cerebral amyloid angiopathy: a 25-year scientometric analysis. Front Neurol 14:1334360. https:\/\/doi.org\/10.3389\/fneur.2023.1334360","journal-title":"Front Neurol"},{"issue":"2","key":"2022_CR70","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s00401-017-1709-7","volume":"134","author":"TL Spires-Jones","year":"2017","unstructured":"Spires-Jones TL, Attems J, Thal DR (2017) Interactions of pathological proteins in neurodegenerative diseases. Acta Neuropathol 134(2):187\u2013205. https:\/\/doi.org\/10.1007\/s00401-017-1709-7","journal-title":"Acta Neuropathol"},{"issue":"1","key":"2022_CR71","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.neuron.2008.06.018","volume":"59","author":"PA Adlard","year":"2008","unstructured":"Adlard PA, Cherny RA, Finkelstein DI, Gautier E, Robb E, Cortes M, Volitakis I, Liu X, Smith JP, Perez K, Laughton K, Li QX, Charman SA, Nicolazzo JA, Wilkins S, Deleva K, Lynch T, Kok G, Ritchie CW, Tanzi RE, Cappai R, Masters CL, Barnham KJ, Bush AI (2008) Rapid restoration of cognition in Alzheimer\u2019s transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial Abeta. Neuron 59(1):43\u201355. https:\/\/doi.org\/10.1016\/j.neuron.2008.06.018","journal-title":"Neuron"},{"issue":"4","key":"2022_CR72","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00018-023-04737-4","volume":"80","author":"E Afram","year":"2023","unstructured":"Afram E, Lauritzen I, Bourgeois A, El Manaa W, Duplan E, Chami M, Valverde A, Charlotte B, Pardossi-Piquard R, Checler F (2023) The \u03b7-secretase-derived APP fragment \u03b7CTF is localized in Golgi, endosomes and extracellular vesicles and contributes to A\u03b2 production. Cell Mol Life Sci 80(4):97. https:\/\/doi.org\/10.1007\/s00018-023-04737-4","journal-title":"Cell Mol Life Sci"},{"issue":"5","key":"2022_CR73","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1523\/JNEUROSCI.22-05-01858.2002","volume":"22","author":"MA Westerman","year":"2002","unstructured":"Westerman MA, Cooper-Blacketer D, Mariash A, Kotilinek L, Kawarabayashi T, Younkin LH, Carlson GA, Younkin SG, Ashe KH (2002) The relationship between A\u03b2 and memory in the Tg2576 mouse model of Alzheimer\u2019s disease. J Neurosci 22(5):1858\u20131867. https:\/\/doi.org\/10.1523\/JNEUROSCI.22-05-01858.2002","journal-title":"J Neurosci"},{"issue":"1","key":"2022_CR74","doi-asserted-by":"publisher","first-page":"e51965","DOI":"10.1371\/journal.pone.0051965","volume":"8","author":"RH Takahashi","year":"2013","unstructured":"Takahashi RH, Capetillo-Zarate E, Lin MT, Milner TA, Gouras GK (2013) Accumulation of intraneuronal beta-amyloid 42 peptides is associated with early changes in microtubule-associated protein 2 in neurites and synapses. PLoS ONE 8(1):e51965. https:\/\/doi.org\/10.1371\/journal.pone.0051965","journal-title":"PLoS ONE"},{"issue":"3","key":"2022_CR75","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.biopsych.2018.10.018","volume":"86","author":"A Pignataro","year":"2019","unstructured":"Pignataro A, Meli G, Pagano R, Fontebasso V, Battistella R, Conforto G, Ammassari-Teule M, Middei S (2019) Activity-induced amyloid-\u03b2 oligomers drive compensatory synaptic rearrangements in brain circuits controlling memory of presymptomatic Alzheimer\u2019s disease mice. Biol Psychiatry 86(3):185\u2013195. https:\/\/doi.org\/10.1016\/j.biopsych.2018.10.018","journal-title":"Biol Psychiatry"},{"issue":"7","key":"2022_CR76","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1016\/j.ymthe.2022.03.024","volume":"30","author":"S Musardo","year":"2022","unstructured":"Musardo S, Therin S, Pelucchi S, D\u2019Andrea L, Stringhi R, Ribeiro A, Manca A, Balducci C, Pagano J, Sala C, Verpelli C, Grieco V, Edefonti V, Forloni G, Gardoni F, Meli G, Di Marino D, Di Luca M, Marcello E (2022) The development of ADAM10 endocytosis inhibitors for the treatment of Alzheimer\u2019s disease. Mol Ther 30(7):2474\u20132490. https:\/\/doi.org\/10.1016\/j.ymthe.2022.03.024","journal-title":"Mol Ther"},{"issue":"28","key":"2022_CR77","doi-asserted-by":"publisher","first-page":"17415","DOI":"10.1074\/jbc.M115.643577","volume":"290","author":"MA Kostylev","year":"2015","unstructured":"Kostylev MA, Kaufman AC, Nygaard HB, Patel P, Haas LT, Gunther EC, Vortmeyer A, Strittmatter SM (2015) Prion-protein-interacting amyloid-\u03b2 oligomers of high molecular weight are tightly correlated with memory impairment in multiple alzheimer mouse models. J Biol Chem 290(28):17415\u201317438. https:\/\/doi.org\/10.1074\/jbc.M115.643577","journal-title":"J Biol Chem"},{"issue":"9","key":"2022_CR78","doi-asserted-by":"publisher","first-page":"6071","DOI":"10.1074\/jbc.M109.069542","volume":"285","author":"JW Wu","year":"2010","unstructured":"Wu JW, Breydo L, Isas JM, Lee J, Kuznetsov YG, Langen R, Glabe C (2010) Fibrillar oligomers nucleate the oligomerization of monomeric amyloid beta but do not seed fibril formation. J Biol Chem 285(9):6071\u20136079. https:\/\/doi.org\/10.1074\/jbc.M109.069542","journal-title":"J Biol Chem"},{"issue":"4","key":"2022_CR79","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s00401-009-0530-3","volume":"118","author":"F Sarsoza","year":"2009","unstructured":"Sarsoza F, Saing T, Kayed R, Dahlin R, Dick M, Broadwater-Hollifield C, Mobley S, Lott I, Doran E, Gillen D, Anderson-Bergman C, Cribbs DH, Glabe C, Head E (2009) A fibril-specific, conformation-dependent antibody recognizes a subset of Abeta plaques in Alzheimer disease, Down syndrome and Tg2576 transgenic mouse brain. Acta Neuropathol 118(4):505\u2013517. https:\/\/doi.org\/10.1007\/s00401-009-0530-3","journal-title":"Acta Neuropathol"},{"issue":"2","key":"2022_CR80","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1111\/j.1471-4159.2007.04972.x","volume":"104","author":"I Maezawa","year":"2008","unstructured":"Maezawa I, Hong HS, Liu R, Wu CY, Cheng RH, Kung MP, Kung HF, Lam KS, Oddo S, Laferla FM, Jin LW (2008) Congo red and thioflavin-T analogs detect Abeta oligomers. J Neurochem 104(2):457\u2013468. https:\/\/doi.org\/10.1111\/j.1471-4159.2007.04972.x","journal-title":"J Neurochem"},{"issue":"49","key":"2022_CR81","doi-asserted-by":"publisher","first-page":"e2210766119","DOI":"10.1073\/pnas.2210766119","volume":"119","author":"M Habashi","year":"2022","unstructured":"Habashi M, Vutla S, Tripathi K, Senapati S, Chauhan PS, Haviv-Chesner A, Richman M, Mohand SA, Dumulon-Perreault V, Mulamreddy R, Okun E, Chill JH, Gu\u00e9rin B, Lubell WD, Rahimipour S (2022) Early diagnosis and treatment of Alzheimer\u2019s disease by targeting toxic soluble A\u03b2 oligomers. Proc Natl Acad Sci U S A 119(49):e2210766119. https:\/\/doi.org\/10.1073\/pnas.2210766119","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"40","key":"2022_CR82","doi-asserted-by":"publisher","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","volume":"26","author":"H Oakley","year":"2006","unstructured":"Oakley H, Cole SL, Logan S, Maus E, Shao P, Craft J, Guillozet-Bongaarts A, Ohno M, Disterhoft J, Van Eldik L, Berry R, Vassar R (2006) Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer\u2019s disease mutations: potential factors in amyloid plaque formation. J Neurosci 26(40):10129\u201310140. https:\/\/doi.org\/10.1523\/JNEUROSCI.1202-06.2006","journal-title":"J Neurosci"},{"issue":"9","key":"2022_CR83","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1038\/s41591-021-01456-w","volume":"27","author":"TA Pascoal","year":"2021","unstructured":"Pascoal TA, Benedet AL, Ashton NJ, Kang MS, Therriault J, Chamoun M, Savard M, Lussier FZ, Tissot C, Karikari TK, Ottoy J, Mathotaarachchi S, Stevenson J, Massarweh G, Sch\u00f6ll M, de Leon MJ, Soucy JP, Edison P, Blennow K, Zetterberg H, Gauthier S, Rosa-Neto P (2021) Microglial activation and tau propagate jointly across Braak stages. Nat Med 27(9):1592\u20131599. https:\/\/doi.org\/10.1038\/s41591-021-01456-w","journal-title":"Nat Med"},{"issue":"2","key":"2022_CR84","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.cell.2019.09.001","volume":"179","author":"JM Long","year":"2019","unstructured":"Long JM, Holtzman DM (2019) Alzheimer disease: an update on pathobiology and treatment strategies. Cell 179(2):312\u2013339. https:\/\/doi.org\/10.1016\/j.cell.2019.09.001","journal-title":"Cell"},{"key":"2022_CR85","doi-asserted-by":"publisher","first-page":"1129036","DOI":"10.3389\/fnsyn.2023.1129036","volume":"15","author":"S Meftah","year":"2023","unstructured":"Meftah S, Gan J (2023) Alzheimer\u2019s disease as a synaptopathy: evidence for dysfunction of synapses during disease progression. Front Synaptic Neurosci 15:1129036. https:\/\/doi.org\/10.3389\/fnsyn.2023.1129036","journal-title":"Front Synaptic Neurosci"},{"issue":"8","key":"2022_CR86","doi-asserted-by":"publisher","first-page":"e42823","DOI":"10.1371\/journal.pone.0042823","volume":"7","author":"W Kamphuis","year":"2012","unstructured":"Kamphuis W, Mamber C, Moeton M, Kooijman L, Sluijs JA, Jansen AH, Verveer M, de Groot LR, Smith VD, Rangarajan S, Rodr\u00edguez JJ, Orre M, Hol EM (2012) GFAP isoforms in adult mouse brain with a focus on neurogenic astrocytes and reactive astrogliosis in mouse models of Alzheimer disease. PLoS ONE 7(8):e42823. https:\/\/doi.org\/10.1371\/journal.pone.0042823","journal-title":"PLoS ONE"},{"key":"2022_CR87","doi-asserted-by":"publisher","first-page":"35719","DOI":"10.1038\/srep35719","volume":"6","author":"L Lorenzini","year":"2016","unstructured":"Lorenzini L, Giuliani A, Sivilia S, Baldassarro VA, Fernandez M, Lotti Margotti M, Giardino L, Fontani V, Rinaldi S, Calz\u00e0 L (2016) REAC technology modifies pathological neuroinflammation and motor behaviour in an Alzheimer\u2019s disease mouse model. Sci Rep 6:35719. https:\/\/doi.org\/10.1038\/srep35719","journal-title":"Sci Rep"},{"issue":"1","key":"2022_CR88","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/s0169-328x(98)00040-0","volume":"57","author":"D Ito","year":"1998","unstructured":"Ito D, Imai Y, Ohsawa K, Nakajima K, Fukuuchi Y, Kohsaka S (1998) Microglia-specific localisation of a novel calcium binding protein, Iba1. Brain Res Mol Brain Res 57(1):1\u20139. https:\/\/doi.org\/10.1016\/s0169-328x(98)00040-0","journal-title":"Brain Res Mol Brain Res"},{"issue":"2","key":"2022_CR89","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1006\/bbrc.2001.5388","volume":"286","author":"Y Sasaki","year":"2001","unstructured":"Sasaki Y, Ohsawa K, Kanazawa H, Kohsaka S, Imai Y (2001) Iba1 is an actin-cross-linking protein in macrophages\/microglia. Biochem Biophys Res Commun 286(2):292\u2013297. https:\/\/doi.org\/10.1006\/bbrc.2001.5388","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"2022_CR90","doi-asserted-by":"publisher","first-page":"17034","DOI":"10.1038\/s41598-017-17313-1","volume":"7","author":"H Rajamohamedsait","year":"2017","unstructured":"Rajamohamedsait H, Rasool S, Rajamohamedsait W, Lin Y, Sigurdsson EM (2017) Prophylactic active tau immunization leads to sustained reduction in both tau and amyloid-\u03b2 pathologies in 3xTg mice. Sci Rep 7(1):17034. https:\/\/doi.org\/10.1038\/s41598-017-17313-1","journal-title":"Sci Rep"},{"issue":"9","key":"2022_CR91","doi-asserted-by":"publisher","first-page":"3745","DOI":"10.1523\/JNEUROSCI.23-09-03745.2003","volume":"23","author":"DM Wilcock","year":"2003","unstructured":"Wilcock DM, DiCarlo G, Henderson D, Jackson J, Clarke K, Ugen KE, Gordon MN, Morgan D (2003) Intracranially administered anti-A\u03b2 antibodies reduce \u03b2-amyloid deposition by mechanisms both independent of and associated with microglial activation. J Neurosci 23(9):3745\u20133751. https:\/\/doi.org\/10.1523\/JNEUROSCI.23-09-03745.2003","journal-title":"J Neurosci"},{"issue":"24","key":"2022_CR92","doi-asserted-by":"publisher","first-page":"8532","DOI":"10.1523\/JNEUROSCI.23-24-08532","volume":"23","author":"P Das","year":"2003","unstructured":"Das P, Howard V, Loosbrock N, Dickson D, Murphy MP, Golde TE (2003) Amyloid-beta immunization effectively reduces amyloid deposition in FcRgamma-\/- knock-out mice. J Neurosci 23(24):8532\u20138538. https:\/\/doi.org\/10.1523\/JNEUROSCI.23-24-08532","journal-title":"J Neurosci"},{"key":"2022_CR93","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1742-2094-3-17","volume":"3","author":"P Das","year":"2006","unstructured":"Das P, Smithson LA, Price RW, Holloway VM, Levites Y, Chakrabarty P, Golde TE (2006) Interleukin-1 receptor 1 knockout has no effect on amyloid deposition in Tg2576 mice and does not alter efficacy following A\u03b2 immunotherapy. J Neuroinflammation 3:17. https:\/\/doi.org\/10.1186\/1742-2094-3-17","journal-title":"J Neuroinflammation"},{"issue":"4","key":"2022_CR94","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/S0002-9440(10)64085-0","volume":"158","author":"Y Matsuoka","year":"2001","unstructured":"Matsuoka Y, Picciano M, Malester B, LaFrancois J, Zehr C, Daeschner JM, Olschowka JA, Fonseca MI, O\u2019Banion MK, Tenner AJ, Lemere CA, Duff K (2001) Inflammatory responses to amyloidosis in a transgenic mouse model of Alzheimer\u2019s disease. Am J Pathol 158(4):1345\u20131354. https:\/\/doi.org\/10.1016\/S0002-9440(10)64085-0","journal-title":"Am J Pathol"},{"key":"2022_CR95","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1742-2094-10-2","volume":"10","author":"P Jin","year":"2013","unstructured":"Jin P, Kim JA, Choi DY, Lee YJ, Jung HS, Hong JT (2013) Anti-inflammatory and anti-amyloidogenic effects of a small molecule, 2,4-bis(p-hydroxyphenyl)-2-butenal in Tg2576 Alzheimer\u2019s disease mice model. J Neuroinflammation 10:2. https:\/\/doi.org\/10.1186\/1742-2094-10-2","journal-title":"J Neuroinflammation"},{"issue":"9","key":"2022_CR96","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1038\/sj.embor.7400784","volume":"7","author":"R Radde","year":"2006","unstructured":"Radde R, Bolmont T, Kaeser SA, Coomaraswamy J, Lindau D, Stoltze L, Calhoun ME, J\u00e4ggi F, Wolburg H, Gengler S, Haass C, Ghetti B, Czech C, H\u00f6lscher C, Mathews PM, Jucker M (2006) Abeta42-driven cerebral amyloidosis in transgenic mice reveals early and robust pathology. EMBO Rep 7(9):940\u2013946. https:\/\/doi.org\/10.1038\/sj.embor.7400784","journal-title":"EMBO Rep"},{"issue":"10","key":"2022_CR97","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1038\/nn.4631","volume":"20","author":"P F\u00fcger","year":"2017","unstructured":"F\u00fcger P, Hefendehl JK, Veeraraghavalu K, Wendeln AC, Schlosser C, Oberm\u00fcller U, Wegenast-Braun BM, Neher JJ, Martus P, Kohsaka S, Thunemann M, Feil R, Sisodia SS, Skodras A, Jucker M (2017) Microglia turnover with aging and in an Alzheimer\u2019s model via long-term in vivo single-cell imaging. Nat Neurosci 20(10):1371\u20131376. https:\/\/doi.org\/10.1038\/nn.4631","journal-title":"Nat Neurosci"},{"key":"2022_CR98","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.bbi.2022.10.009","volume":"107","author":"MSJ Kater","year":"2023","unstructured":"Kater MSJ, Huffels CFM, Oshima T, Renckens NS, Middeldorp J, Boddeke EWGM, Smit AB, Eggen BJL, Hol EM, Verheijen MHG (2023) Prevention of microgliosis halts early memory loss in a mouse model of Alzheimer\u2019s disease. Brain Behav Immun 107:225\u2013241. https:\/\/doi.org\/10.1016\/j.bbi.2022.10.009","journal-title":"Brain Behav Immun"},{"issue":"2","key":"2022_CR99","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1002\/cne.21176","volume":"500","author":"H Dong","year":"2007","unstructured":"Dong H, Martin MV, Chambers S, Csernansky JG (2007) Spatial relationship between synapse loss and \u03b2-amyloid deposition in Tg2576 mice. J Comp Neurol 500(2):311\u2013321. https:\/\/doi.org\/10.1002\/cne.21176","journal-title":"J Comp Neurol"},{"issue":"15","key":"2022_CR100","doi-asserted-by":"publisher","first-page":"3801","DOI":"10.1523\/JNEUROSCI.5543-03.2004","volume":"24","author":"T Kawarabayashi","year":"2004","unstructured":"Kawarabayashi T, Shoji M, Younkin LH, Wen-Lang L, Dickson DW, Murakami T, Matsubara E, Abe K, Ashe KH, Younkin SG (2004) Dimeric amyloid beta protein rapidly accumulates in lipid rafts followed by apolipoprotein E and phosphorylated tau accumulation in the Tg2576 mouse model of Alzheimer\u2019s disease. J Neurosci 24(15):3801\u20133809. https:\/\/doi.org\/10.1523\/JNEUROSCI.5543-03.2004","journal-title":"J Neurosci"},{"issue":"5","key":"2022_CR101","doi-asserted-by":"publisher","first-page":"417","DOI":"10.3233\/jad-2002-4508","volume":"4","author":"C Otth","year":"2002","unstructured":"Otth C, Concha II, Arendt T, Stieler J, Schliebs R, Gonzalez-Billault C, Maccioni RB (2002) AbetaPP induces cdk5-dependent tau hyperphosphorylation in transgenic mice Tg2576. J Alzheimers Dis 4(5):417\u2013430. https:\/\/doi.org\/10.3233\/jad-2002-4508","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"2022_CR102","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/s0304-3940(00)01767-5","volume":"299","author":"K Tomidokoro","year":"2001","unstructured":"Tomidokoro K, Ishiguro Y, Harigaya E, Matsubara M, Ikeda JM, Park K, Yasutake T, Kawarabayashi K, Okamoto M, Shoji M (2001) Abeta amyloidosis induces the initial stage of tau accumulation in APP(Sw) mice. Neurosci Lett 299(3):169\u2013172. https:\/\/doi.org\/10.1016\/s0304-3940(00)01767-5","journal-title":"Neurosci Lett"},{"key":"2022_CR103","doi-asserted-by":"publisher","first-page":"105010","DOI":"10.1016\/j.nbd.2020.105010","volume":"144","author":"SS Plotkin","year":"2020","unstructured":"Plotkin SS, Cashman NR (2020) Passive immunotherapies targeting Abeta and tau in Alzheimer\u2019s disease. Neurobiol Dis 144:105010. https:\/\/doi.org\/10.1016\/j.nbd.2020.105010","journal-title":"Neurobiol Dis"},{"issue":"4","key":"2022_CR104","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s00702-014-1315-y","volume":"122","author":"CL Dai","year":"2015","unstructured":"Dai CL, Chen X, Kazim SF, Liu F, Gong CX, Grundke-Iqbal I, Iqbal K (2015) Passive immunization targeting the N-terminal projection domain of tau decreases tau pathology and improves cognition in a transgenic mouse model of Alzheimer disease and tauopathies. J Neural Transm (Vienna) 122(4):607\u2013617. https:\/\/doi.org\/10.1007\/s00702-014-1315-y","journal-title":"J Neural Transm (Vienna)"},{"issue":"1","key":"2022_CR105","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13195-016-0227-5","volume":"9","author":"CL Dai","year":"2017","unstructured":"Dai CL, Tung YC, Liu F, Gong CX, Iqbal K (2017) Tau passive immunization inhibits not only tau but also A\u03b2 pathology. Alzheimers Res Ther 9(1):1. https:\/\/doi.org\/10.1186\/s13195-016-0227-5","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"2022_CR106","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13195-018-0341-7","volume":"10","author":"CL Dai","year":"2018","unstructured":"Dai CL, Hu W, Tung YC, Liu F, Gong CX, Iqbal K (2018) Tau passive immunization blocks seeding and spread of Alzheimer hyperphosphorylated Tau-induced pathology in 3 \u00d7 Tg-AD mice. Alzheimers Res Ther 10(1):13. https:\/\/doi.org\/10.1186\/s13195-018-0341-7","journal-title":"Alzheimers Res Ther"},{"issue":"15","key":"2022_CR107","doi-asserted-by":"publisher","first-page":"4964","DOI":"10.1523\/JNEUROSCI.4560-08.2009","volume":"29","author":"RA Karlnoski","year":"2009","unstructured":"Karlnoski RA, Rosenthal A, Kobayashi D, Pons J, Alamed J, Mercer M, Li Q, Gordon MN, Gottschall PE, Morgan D (2009) Suppression of amyloid deposition leads to long-term reductions in Alzheimer\u2019s pathologies in Tg2576 mice. J Neurosci 29(15):4964\u20134971. https:\/\/doi.org\/10.1523\/JNEUROSCI.4560-08.2009","journal-title":"J Neurosci"},{"issue":"12","key":"2022_CR108","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1038\/s41593-020-00737-w","volume":"23","author":"RE Uhlmann","year":"2020","unstructured":"Uhlmann RE, Rother C, Rasmussen J, Schelle J, Bergmann C, Ullrich Gavilanes EM, Fritschi SK, Buehler A, Baumann F, Skodras A, Al-Shaana R, Beschorner N, Ye L, Kaeser SA, Oberm\u00fcller U, Christensen S, Kartberg F, Stavenhagen JB, Rahfeld JU, Cynis H, Qian F, Weinreb PH, Bussiere T, Walker LC, Staufenbiel M, Jucker M (2020) Acute targeting of pre-amyloid seeds in transgenic mice reduces Alzheimer-like pathology later in life. Nat Neurosci 23(12):1580\u20131588. https:\/\/doi.org\/10.1038\/s41593-020-00737-w","journal-title":"Nat Neurosci"},{"issue":"1","key":"2022_CR109","doi-asserted-by":"publisher","first-page":"7333","DOI":"10.1038\/s41467-022-34538-5","volume":"13","author":"C Rother","year":"2022","unstructured":"Rother C, Uhlmann RE, M\u00fcller SA, Schelle J, Skodras A, Oberm\u00fcller U, H\u00e4sler LM, Lambert M, Baumann F, Xu Y, Bergmann C, Salvadori G, Loos M, Brzak I, Shimshek D, Neumann U, Walker LC, Schultz SA, Chhatwal JP, Kaeser SA, Lichtenthaler SF, Staufenbiel M, Jucker M (2022) Experimental evidence for temporal uncoupling of brain Abeta deposition and neurodegenerative sequelae. Nat Commun 13(1):7333. https:\/\/doi.org\/10.1038\/s41467-022-34538-5","journal-title":"Nat Commun"},{"issue":"4","key":"2022_CR110","doi-asserted-by":"publisher","first-page":"3895","DOI":"10.3390\/ijms24043895","volume":"24","author":"AS Vogt","year":"2023","unstructured":"Vogt AS, Jennings GT, Mohsen MO, Vogel M, Bachmann MF (2023) Alzheimer\u2019s disease: a brief history of immunotherapies targeting amyloid \u03b2. Int J Mol Sci 24(4):3895. https:\/\/doi.org\/10.3390\/ijms24043895","journal-title":"Int J Mol Sci"},{"issue":"9","key":"2022_CR111","doi-asserted-by":"publisher","first-page":"e1347","DOI":"10.1212\/WNL.0000000000011524","volume":"96","author":"WJ Jagust","year":"2021","unstructured":"Jagust WJ, Landau SM, Initiative ADN (2021) Temporal dynamics of \u03b2-amyloid accumulation in aging and Alzheimer disease. Neurology 96(9):e1347\u2013e1357. https:\/\/doi.org\/10.1212\/WNL.0000000000011524","journal-title":"Neurology"},{"issue":"10","key":"2022_CR112","doi-asserted-by":"publisher","first-page":"5481","DOI":"10.1038\/s41380-021-01249-0","volume":"26","author":"H Hampel","year":"2021","unstructured":"Hampel H, Hardy J, Blennow K, Chen C, Perry G, Kim SH, Villemagne VL, Aisen P, Vendruscolo M, Iwatsubo T, Masters CL, Cho M, Lannfelt L, Cummings JL, Vergallo A (2021) The amyloid-\u03b2 pathway in Alzheimer\u2019s disease. Mol Psychiatry 26(10):5481\u20135503. https:\/\/doi.org\/10.1038\/s41380-021-01249-0","journal-title":"Mol Psychiatry"},{"issue":"4","key":"2022_CR113","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.neurobiolaging.2005.04.017","volume":"27","author":"CG Glabe","year":"2006","unstructured":"Glabe CG (2006) Common mechanisms of amyloid oligomer pathogenesis in degenerative disease. Neurobiol Aging 27(4):570\u2013575. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2005.04.017","journal-title":"Neurobiol Aging"},{"issue":"44","key":"2022_CR114","doi-asserted-by":"publisher","first-page":"29639","DOI":"10.1074\/jbc.R800016200","volume":"283","author":"CG Glabe","year":"2008","unstructured":"Glabe CG (2008) Structural classification of toxic amyloid oligomers. J Biol Chem 283(44):29639\u201329643. https:\/\/doi.org\/10.1074\/jbc.R800016200","journal-title":"J Biol Chem"},{"issue":"5","key":"2022_CR115","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/nsmb.1799","volume":"17","author":"M Ahmed","year":"2010","unstructured":"Ahmed M, Davis J, Aucoin D, Sato T, Ahuja S, Aimoto S, Elliott JI, Van Nostrand WE, Smith SO (2010) Structural conversion of neurotoxic amyloid-beta(1\u201342) oligomers to fibrils. Nat Struct Mol Biol 17(5):561\u2013567. https:\/\/doi.org\/10.1038\/nsmb.1799","journal-title":"Nat Struct Mol Biol"},{"key":"2022_CR116","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ebiom.2016.03.035","volume":"6","author":"U Sengupta","year":"2016","unstructured":"Sengupta U, Nilson AN, Kayed R (2016) The role of amyloid-\u03b2 oligomers in toxicity, propagation, and immunotherapy. EBioMedicine 6:42\u201349. https:\/\/doi.org\/10.1016\/j.ebiom.2016.03.035","journal-title":"EBioMedicine"},{"issue":"2","key":"2022_CR117","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s00401-015-1386-3","volume":"129","author":"KL Viola","year":"2015","unstructured":"Viola KL, Klein WL (2015) Amyloid \u03b2 oligomers in Alzheimer\u2019s disease pathogenesis, treatment, and diagnosis. Acta Neuropathol 129(2):183\u2013206. https:\/\/doi.org\/10.1007\/s00401-015-1386-3","journal-title":"Acta Neuropathol"},{"issue":"5","key":"2022_CR118","doi-asserted-by":"publisher","first-page":"418","DOI":"10.2174\/1567205016666190321163438","volume":"16","author":"L Pinheiro","year":"2019","unstructured":"Pinheiro L, Faustino C (2019) Therapeutic strategies targeting amyloid-\u03b2 in Alzheimer\u2019s disease. Curr Alzheimer Res 16(5):418\u2013452. https:\/\/doi.org\/10.2174\/1567205016666190321163438","journal-title":"Curr Alzheimer Res"},{"issue":"34","key":"2022_CR119","doi-asserted-by":"publisher","first-page":"10582","DOI":"10.1523\/JNEUROSCI.1736-09.2009","volume":"29","author":"ML Giuffrida","year":"2009","unstructured":"Giuffrida ML, Caraci F, Pignataro B, Cataldo S, De Bona P, Bruno V, Molinaro G, Pappalardo G, Messina A, Palmigiano A, Garozzo D, Nicoletti F, Rizzarelli E (2009) Copani A (2009) Beta-amyloid monomers are neuroprotective. J Neurosci 29(34):10582\u201310587. https:\/\/doi.org\/10.1523\/JNEUROSCI.1736-09.2009","journal-title":"J Neurosci"},{"key":"2022_CR120","doi-asserted-by":"publisher","first-page":"118","DOI":"10.3389\/fnagi.2018.00118","volume":"10","author":"HM Brothers","year":"2018","unstructured":"Brothers HM, Gosztyla ML, Robinson SR (2018) The physiological roles of amyloid-beta peptide hint at new ways to treat alzheimer\u2019s disease. Front Aging Neurosci 10:118. https:\/\/doi.org\/10.3389\/fnagi.2018.00118","journal-title":"Front Aging Neurosci"},{"issue":"4","key":"2022_CR121","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s00401-020-02196-w","volume":"140","author":"SA Kent","year":"2020","unstructured":"Kent SA, Spires-Jones TL, Durrant CS (2020) The physiological roles of tau and A\u03b2: implications for Alzheimer\u2019s disease pathology and therapeutics. Acta Neuropathol 140(4):417\u2013447. https:\/\/doi.org\/10.1007\/s00401-020-02196-w","journal-title":"Acta Neuropathol"},{"key":"2022_CR122","doi-asserted-by":"publisher","first-page":"109002","DOI":"10.1016\/j.neuropharm.2022.109002","volume":"209","author":"Y Duan","year":"2022","unstructured":"Duan Y, Lv J, Zhang Z, Chen Z, Wu H, Chen J, Chen Z, Yang J, Wang D, Liu Y, ChenF Tian Y, Cao X (2022) Exogenous A\u03b21\u201342 monomers improve synaptic and cognitive function in Alzheimer\u2019s disease model mice. Neuropharmacology 209:109002. https:\/\/doi.org\/10.1016\/j.neuropharm.2022.109002","journal-title":"Neuropharmacology"},{"issue":"10","key":"2022_CR123","doi-asserted-by":"publisher","first-page":"3513","DOI":"10.1093\/brain\/awae216","volume":"147","author":"J Abanto","year":"2024","unstructured":"Abanto J, Dwivedi AK, Imbimbo BP, Espay AJ (2024) Increases in amyloid-\u03b242 slow cognitive and clinical decline in Alzheimer\u2019s disease trials. Brain 147(10):3513\u20133521. https:\/\/doi.org\/10.1093\/brain\/awae216","journal-title":"Brain"},{"issue":"53","key":"2022_CR124","doi-asserted-by":"publisher","first-page":"14537","DOI":"10.1523\/JNEUROSCI.2692-08.2008","volume":"28","author":"D Puzzo","year":"2008","unstructured":"Puzzo D, Privitera L, Leznik E, Fa M, Staniszewski A, Palmeri A, Arancio O (2008) Picomolar amyloid-beta positively modulates synaptic plasticity and memory in hippocampus. J Neurosci 28(53):14537\u201314545. https:\/\/doi.org\/10.1523\/JNEUROSCI.2692-08.2008","journal-title":"J Neurosci"},{"issue":"9","key":"2022_CR125","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3389\/fncel.2015.00297","volume":"7","author":"ML Giuffrida","year":"2015","unstructured":"Giuffrida ML, Tomasello MF, Pandini G, Caraci F, Battaglia G, Busceti C, Di Pietro P, Pappalardo G, Attanasio F, Chiechio S, Bagnoli S, Nacmias B, Sorbi S, Vigneri R, Rizzarelli E, Nicoletti F, Copani A (2015) Monomeric ss-amyloid interacts with type-1 insulin-like growth factor receptors to provide energy supply to neurons. Front Cell Neurosci 7(9):297. https:\/\/doi.org\/10.3389\/fncel.2015.00297","journal-title":"Front Cell Neurosci"},{"issue":"19","key":"2022_CR126","doi-asserted-by":"publisher","first-page":"14499","DOI":"10.3390\/ijms241914499","volume":"24","author":"E Fedele","year":"2023","unstructured":"Fedele E (2023) Anti-amyloid therapies for alzheimer\u2019s disease and the amyloid cascade hypothesis. Int J Mol Sci 24(19):14499. https:\/\/doi.org\/10.3390\/ijms241914499","journal-title":"Int J Mol Sci"},{"issue":"8","key":"2022_CR127","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1007\/s12264-022-00985-9","volume":"39","author":"W Cai","year":"2023","unstructured":"Cai W, Li L, Sang S, Pan X, Zhong C (2023) Physiological roles of \u03b2-amyloid in regulating synaptic function: implications for AD pathophysiology. Neurosci Bull 39(8):1289\u20131308. https:\/\/doi.org\/10.1007\/s12264-022-00985-9","journal-title":"Neurosci Bull"},{"issue":"1","key":"2022_CR128","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/s41392-023-01484-7","volume":"8","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Chen H, Li R, Sterling K, Song W (2023) Amyloid \u03b2-based therapy for Alzheimer\u2019s disease: challenges, successes and future. Signal Transduct Target Ther 8(1):248. https:\/\/doi.org\/10.1038\/s41392-023-01484-7","journal-title":"Signal Transduct Target Ther"},{"issue":"5597","key":"2022_CR129","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1126\/science.1078259","volume":"298","author":"M Pfeifer","year":"2002","unstructured":"Pfeifer M, Boncristiano S, Bondolfi L, Stalder A, Deller T, Staufenbiel M, Mathews PM, Jucker M (2002) Cerebral hemorrhage after passive anti-Abeta immunotherapy. Science 298(5597):1379. https:\/\/doi.org\/10.1126\/science.1078259","journal-title":"Science"},{"issue":"3","key":"2022_CR130","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1523\/JNEUROSCI.4337-04.2005","volume":"25","author":"MM Racke","year":"2005","unstructured":"Racke MM, Boone LI, Hepburn DL, Parsadainian M, Bryan MT, Ness DK, Piroozi KS, Jordan WH, Brown DD, Hoffman WP, Holtzman DM, Bales KR, Gitter BD, May PC, Paul SM, DeMattos RB (2005) Exacerbation of cerebral amyloid angiopathy-associated microhemorrhage in amyloid precursor protein transgenic mice by immunotherapy is dependent on antibody recognition of deposited forms of amyloid beta. J Neurosci 25(3):629\u2013636. https:\/\/doi.org\/10.1523\/JNEUROSCI.4337-04.2005","journal-title":"J Neurosci"},{"issue":"5 Suppl","key":"2022_CR131","doi-asserted-by":"publisher","first-page":"S105","DOI":"10.1016\/j.jalz.2012.11.010","volume":"9","author":"W Zago","year":"2013","unstructured":"Zago W, Schroeter S, Guido T, Khan K, Seubert P, Yednock T, Schenk D, Gregg KM, Games D, Bard F, Kinney GG (2013) Vascular alterations in PDAPP mice after anti-Abeta immunotherapy: Implications for amyloid-related imaging abnormalities. Alzheimers Dement 9(5 Suppl):S105\u2013S115. https:\/\/doi.org\/10.1016\/j.jalz.2012.11.010","journal-title":"Alzheimers Dement"},{"issue":"4","key":"2022_CR132","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.3233\/JAD-170056","volume":"59","author":"S Villarreal","year":"2017","unstructured":"Villarreal S, Zhao F, Hyde LA, Holder D, Forest T, Sondey M, Chen X, Sur C, Parker EM, Kennedy ME (2017) Chronic verubecestat treatment suppresses amyloid accumulation in advanced aged Tg2576-A\u03b2PPswe mice without inducing microhemorrhage. J Alzheimers Dis 59(4):1393\u20131413. https:\/\/doi.org\/10.3233\/JAD-170056","journal-title":"J Alzheimers Dis"},{"key":"2022_CR133","doi-asserted-by":"publisher","first-page":"105365","DOI":"10.1016\/j.nbd.2021.105365","volume":"154","author":"J Janssens","year":"2021","unstructured":"Janssens J, Hermans B, Vandermeeren M, Barale-Thomas E, Borgers M, Willems R, Meulders G, Wintmolders C, Van den Bulck D, Bottelbergs A, Ver Donck L, Larsen P, Moechars D, Edwards W, Mercken M, Van Broeck B (2021) Passive immunotherapy with a novel antibody against 3pE-modified A\u03b2 demonstrates potential for enhanced efficacy and favorable safety in combination with BACE inhibitor treatment in plaque-depositing mice. Neurobiol Dis 154:105365. https:\/\/doi.org\/10.1016\/j.nbd.2021.105365","journal-title":"Neurobiol Dis"},{"issue":"1","key":"2022_CR134","doi-asserted-by":"publisher","first-page":"50","DOI":"10.2174\/187152709787601858","volume":"8","author":"DM Wilcock","year":"2009","unstructured":"Wilcock DM, Colton CA (2009) Immunotherapy, vascular pathology, and microhemorrhages in transgenic mice. CNS Neurol Disord Drug Targets 8(1):50\u201364. https:\/\/doi.org\/10.2174\/187152709787601858","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"1","key":"2022_CR135","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s13024-023-00649-w","volume":"18","author":"X Taylor","year":"2023","unstructured":"Taylor X, Clark IM, Fitzgerald GJ, Oluoch H, Hole JT, DeMattos RB, Wang Y, Pan F (2023) Amyloid-beta (Abeta) immunotherapy induced microhemorrhages are associated with activated perivascular macrophages and peripheral monocyte recruitment in Alzheimer\u2019s disease mice. Mol Neurodegener 18(1):59. https:\/\/doi.org\/10.1186\/s13024-023-00649-w","journal-title":"Mol Neurodegener"},{"issue":"6","key":"2022_CR136","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1016\/j.neuron.2014.12.064","volume":"85","author":"T Wisniewski","year":"2015","unstructured":"Wisniewski T, Go\u00f1i F (2015) Immunotherapeutic approaches for alzheimer\u2019s disease. Neuron 85(6):1162\u20131176. https:\/\/doi.org\/10.1016\/j.neuron.2014.12.064","journal-title":"Neuron"},{"issue":"3","key":"2022_CR137","doi-asserted-by":"publisher","first-page":"715","DOI":"10.3233\/JAD-190507","volume":"71","author":"DR Elmaleh","year":"2019","unstructured":"Elmaleh DR, Farlow MR, Conti PS, Tompkins RG, Kundakovic L, Tanzi RE (2019) Developing effective alzheimer\u2019s disease therapies: clinical experience and future directions. J Alzheimers Dis 71(3):715\u2013732. https:\/\/doi.org\/10.3233\/JAD-190507","journal-title":"J Alzheimers Dis"},{"issue":"20","key":"2022_CR138","doi-asserted-by":"publisher","first-page":"4260","DOI":"10.1016\/j.cell.2023.08.021","volume":"186","author":"M Jucker","year":"2023","unstructured":"Jucker M, Walker LC (2023) Alzheimer\u2019s disease: From immunotherapy to immunoprevention. Cell 186(20):4260\u20134270. https:\/\/doi.org\/10.1016\/j.cell.2023.08.021","journal-title":"Cell"},{"issue":"1","key":"2022_CR139","doi-asserted-by":"publisher","first-page":"117","DOI":"10.4103\/1673-5374.340409","volume":"18","author":"BP Imbimbo","year":"2023","unstructured":"Imbimbo BP, Balducci C, Ippati S, Watling M (2023) Initial failures of anti-tau antibodies in Alzheimer\u2019s disease are reminiscent of the amyloid-beta story. Neural Regen Res 18(1):117\u2013118. https:\/\/doi.org\/10.4103\/1673-5374.340409","journal-title":"Neural Regen Res"},{"issue":"7","key":"2022_CR140","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1002\/eji.1830160727","volume":"16","author":"P Vieira","year":"1986","unstructured":"Vieira P, Rajewsky K (1986) The bulk of endogenously produced IgG2a is eliminated from the serum of adult C57BL\/6 mice with a half-life of 6\u20138 days. Eur J Immunol 16(7):871\u2013874. https:\/\/doi.org\/10.1002\/eji.1830160727","journal-title":"Eur J Immunol"},{"issue":"2","key":"2022_CR141","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1002\/eji.1830180221","volume":"18","author":"P Vieira","year":"1988","unstructured":"Vieira P, Rajewsky K (1988) The half-lives of serum immunoglobulins in adult mice. Eur J Immunol 18(2):313\u2013316. https:\/\/doi.org\/10.1002\/eji.1830180221","journal-title":"Eur J Immunol"},{"issue":"1","key":"2022_CR142","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13024-017-0172-1","volume":"12","author":"MG Agadjanyan","year":"2017","unstructured":"Agadjanyan MG, Zagorski K, Petrushina I, Davtyan H, Kazarian K, Antonenko M, Davis J, Bon C, Blurton-Jones M, Cribbs DH, Ghochikyan A (2017) Humanized monoclonal antibody armanezumab specific to N-terminus of pathological tau: characterization and therapeutic potency. Mol Neurodegener 12(1):33. https:\/\/doi.org\/10.1186\/s13024-017-0172-1","journal-title":"Mol Neurodegener"},{"issue":"12","key":"2022_CR143","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1016\/s0196-9781(02)00261-9","volume":"23","author":"WA Banks","year":"2002","unstructured":"Banks WA, Terrell B, Farr SA, Robinson SM, Nonaka N, Morley JE (2002) Passage of amyloid beta protein antibody across the blood-brain barrier in a mouse model of Alzheimer\u2019s disease. Peptides 23(12):2223\u20132226. https:\/\/doi.org\/10.1016\/s0196-9781(02)00261-9","journal-title":"Peptides"},{"issue":"11","key":"2022_CR144","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.1038\/s41593-024-01763-8","volume":"27","author":"J Gallego-Rudolf","year":"2024","unstructured":"Gallego-Rudolf J, Wiesman AI, Pichet Binette A, Villeneuve S, Baillet S, PREVENT-AD research group (2024) Synergistic association of A\u03b2 and tau pathology with cortical neurophysiology and cognitive decline in asymptomatic older adults. Nat Neurosci 27(11):2130\u20132137. https:\/\/doi.org\/10.1038\/s41593-024-01763-8","journal-title":"Nat Neurosci"},{"issue":"6","key":"2022_CR145","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1073\/pnas.0509386103","volume":"103","author":"JP Guo","year":"2006","unstructured":"Guo JP, Arai T, Miklossy J, McGeer PL (2006) Abeta and tau form soluble complexes that may promote self aggregation of both into the insoluble forms observed in Alzheimer\u2019s disease. Proc Natl Acad Sci U S A 103(6):1953\u20131958. https:\/\/doi.org\/10.1073\/pnas.0509386103","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"23","key":"2022_CR146","doi-asserted-by":"publisher","first-page":"5172","DOI":"10.1021\/bi200400u","volume":"50","author":"Y Miller","year":"2011","unstructured":"Miller Y, Ma B, Nussinov R (2011) Synergistic interactions between repeats in tau protein and A\u03b2 amyloids may be responsible for accelerated aggregation via polymorphic states. Biochemistry 50(23):5172\u20135181. https:\/\/doi.org\/10.1021\/bi200400u","journal-title":"Biochemistry"},{"issue":"4","key":"2022_CR147","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s00401-015-1525-x","volume":"131","author":"B Vasconcelos","year":"2016","unstructured":"Vasconcelos B, Stancu IC, Buist A, Bird M, Wang P, Vanoosthuyse A, Van Kolen K, Verheyen A, Kienlen-Campard P, Octave JN, Baatsen P, Moechars D, Dewachter I (2016) Heterotypic seeding of Tau fibrillization by pre-aggregated Abeta provides potent seeds for prion-like seeding and propagation of Tau-pathology in vivo. Acta Neuropathol 131(4):549\u2013569. https:\/\/doi.org\/10.1007\/s00401-015-1525-x","journal-title":"Acta Neuropathol"},{"issue":"46","key":"2022_CR148","doi-asserted-by":"publisher","first-page":"7267","DOI":"10.1039\/c9tb01871a","volume":"7","author":"B Ren","year":"2019","unstructured":"Ren B, Zhang Y, Zhang M, Liu Y, Zhang D, Gong X, Feng Z, Tang J, Chang Y, Zheng J (2019) Fundamentals of cross-seeding of amyloid proteins: an introduction. J Mater Chem B 7(46):7267\u20137282. https:\/\/doi.org\/10.1039\/c9tb01871a","journal-title":"J Mater Chem B"},{"key":"2022_CR149","doi-asserted-by":"publisher","first-page":"e46924","DOI":"10.7554\/eLife.46924","volume":"8","author":"SL Griner","year":"2019","unstructured":"Griner SL, Seidler P, Bowler J, Murray KA, Yang TP, Sahay S, Sawaya MR, Cascio D, Rodriguez JA, Philipp S, Sosna J, Glabe CG, Gonen T, Eisenberg DS (2019) Structure-based inhibitors of amyloid beta core suggest a common interface with tau. Elife 8:e46924. https:\/\/doi.org\/10.7554\/eLife.46924","journal-title":"Elife"},{"issue":"4","key":"2022_CR150","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1021\/acs.biochem.9b01087","volume":"59","author":"T Tripathi","year":"2020","unstructured":"Tripathi T, Khan H (2020) Direct interaction between the \u03b2-amyloid core and tau facilitates cross-seeding: a novel target for therapeutic intervention. Biochemistry 59(4):341\u2013342. https:\/\/doi.org\/10.1021\/acs.biochem.9b01087","journal-title":"Biochemistry"},{"issue":"4","key":"2022_CR151","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.neuron.2023.11.014","volume":"112","author":"J Giorgio","year":"2024","unstructured":"Giorgio J, Adams JN, Maass A, Jagust WJ, Breakspear M (2024) Amyloid induced hyperexcitability in default mode network drives medial temporal hyperactivity and early tau accumulation. Neuron 112(4):676-686.e4. https:\/\/doi.org\/10.1016\/j.neuron.2023.11.014","journal-title":"Neuron"},{"issue":"11","key":"2022_CR152","doi-asserted-by":"publisher","first-page":"3058","DOI":"10.1093\/hmg\/ddv059","volume":"24","author":"V Corsetti","year":"2015","unstructured":"Corsetti V, Florenzano F, Atlante A, Bobba A, Ciotti MT, Natale F, Della Valle F, Borreca A, Manca A, Meli G, Ferraina C, Feligioni M, D\u2019Aguanno S, Bussani R, Ammassari-Teule M, Nicolin V, Calissano P, Amadoro G (2015) NH2-truncated human tau induces deregulated mitophagy in neurons by aberrant recruitment of Parkin and UCHL-1: implications in Alzheimer\u2019s disease. Hum Mol Genet 24(11):3058\u20133081. https:\/\/doi.org\/10.1093\/hmg\/ddv059","journal-title":"Hum Mol Genet"},{"key":"2022_CR153","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.ica.2017.09.061","volume":"472","author":"G Di Natale","year":"2018","unstructured":"Di Natale G, Bellia F, Sciacca MFM, Campagna T, Pappalardo G (2018) Tau-peptide fragments and their copper(II) complexes: effects on amyzloid-\u03b2 aggregation. Inorg Chim Acta 472:82\u201392. https:\/\/doi.org\/10.1016\/j.ica.2017.09.061","journal-title":"Inorg Chim Acta"},{"issue":"16","key":"2022_CR154","doi-asserted-by":"publisher","first-page":"5066","DOI":"10.3390\/molecules27165066","volume":"27","author":"G Di Natale","year":"2022","unstructured":"Di Natale G, Sabatino G, Sciacca MFM, Tosto R, Milardi D, Pappalardo G (2022) A\u03b2 and tau interact with metal ions, lipid membranes and peptide-based amyloid inhibitors: are these common features relevant in alzheimer\u2019s disease? Molecules 27(16):5066. https:\/\/doi.org\/10.3390\/molecules27165066","journal-title":"Molecules"},{"key":"2022_CR155","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.neurobiolaging.2014.09.007","volume":"36","author":"J Bright","year":"2015","unstructured":"Bright J, Hussain S, Dang V, Wright S, Cooper B, Byun T, Ramos C, Singh A, Parry G, Stagliano N, Griswold-Prenner I (2015) Human secreted tau increases amyloid-beta production. Neurobiol Aging 36:693\u2013709","journal-title":"Neurobiol Aging"},{"issue":"2","key":"2022_CR156","doi-asserted-by":"publisher","first-page":"e34","DOI":"10.1371\/journal.pbio.1000034","volume":"7","author":"MD Mukrasch","year":"2009","unstructured":"Mukrasch MD, Bibow S, Korukottu J, Jeganathan S, Biernat J, Griesinger C, Mandelkow E, Zweckstetter M (2009) Structural polymorphism of 441-residue tau at single residue resolution. PLoS Biol 7(2):e34. https:\/\/doi.org\/10.1371\/journal.pbio.1000034","journal-title":"PLoS Biol"},{"key":"2022_CR157","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.ijbiomac.2019.08.220","volume":"141","author":"G Perini","year":"2019","unstructured":"Perini G, Ciasca G, Minelli E, Papi M, Palmieri V, Maulucci G, Nardini M, Latina V, Corsetti V, Florenzano F, Calissano P, De Spirito M, Amadoro G (2019) Dynamic structural determinants underlie the neurotoxicity of the N-terminal tau 26\u201344 peptide in Alzheimer\u2019s disease and other human tauopathies. Int J Biol Macromol 141:278\u2013289. https:\/\/doi.org\/10.1016\/j.ijbiomac.2019.08.220","journal-title":"Int J Biol Macromol"},{"key":"2022_CR158","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/s41582-023-00883-2","volume":"19","author":"EE Congdon","year":"2023","unstructured":"Congdon EE, Ji C, Tetlow AM, Jiang Y, Sigurdsson EM (2023) Tau-targeting therapies for Alzheimer disease: current status and future directions. Nat Rev Neurol 19:715\u2013736. https:\/\/doi.org\/10.1038\/s41582-023-00883-2","journal-title":"Nat Rev Neurol"},{"key":"2022_CR159","doi-asserted-by":"publisher","first-page":"32131","DOI":"10.1074\/jbc.M114.594846","volume":"289","author":"A Hatami","year":"2014","unstructured":"Hatami A, Albay R 3rd, Monjazeb S, Milton S, Glabe C (2014) Monoclonal antibodies against A\u03b242 fibrils distinguish multiple aggregation state polymorphisms in vitro and in Alzheimer disease brain. J Biol Chem 289:32131\u201332143. https:\/\/doi.org\/10.1074\/jbc.M114.594846","journal-title":"J Biol Chem"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-025-02022-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40478-025-02022-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-025-02022-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T12:14:15Z","timestamp":1748520855000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-025-02022-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,29]]},"references-count":159,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2022"],"URL":"https:\/\/doi.org\/10.1186\/s40478-025-02022-y","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,29]]},"assertion":[{"value":"13 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were complied with the ARRIVE guidelines and were carried out in accordance with the etical guidelines, the European Council Directive (2010\/63\/EU) and the Italian Animal Welfare legislation (D.L. 26\/2014). The experimental approval was obtained from the Italian Ministry of Health (Authorization n. 1038\u20132020-PR; Authorization n. 419\/2023-PR). This study was carried out according to the principles of the 3Rs (Replacement, Reduction and Refinement) to minimize animal suffering and to reduce the number of animals used.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have approved the manuscript and agree with its submission.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare there are no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"121"}}